Merck CEO & Kimmel’s Return 9/24/25 episode artwork

EPISODE · Sep 24, 2025 · 40 MIN

Merck CEO & Kimmel’s Return 9/24/25

from Squawk Pod · host CNBC

The FDA has approved the injectable version of Merck’s cancer therapy Keytruda. Merck CEO Robert Davis discusses the pricing of this drug and others with CNBC’s Angelica Peebles, Joe Kernen, Becky Quick, and Andrew Ross Sorkin. Davis also stands firm on the safety of vaccines and weighs in on the Trump administration’s agenda for health care. Jimmy Kimmel has returned to ABC’s airwaves. Puck’s Matt Belloni discusses the host’s temporary suspension, Kimmel’s response, and the contractual obligations of Disney’s affiliates Nexstar and Sinclair. Plus, the U.S. has barred Iran’s diplomats from shopping at wholesale stores like Costco without permission.  Matt Belloni - 15:12Robert Davis - 28:47 In this episodeMatt Belloni, @mattbelloniJoe Kernen, @JoeSquawk Becky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Sep 24, 2025

Embed this episode

NOW PLAYING

Merck CEO & Kimmel’s Return 9/24/25

0:00 40:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Squawk Pod?

This episode is 40 minutes long.

When was this Squawk Pod episode published?

This episode was published on September 24, 2025.

Can I download this Squawk Pod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!